Background: Mechanisms that confer an ability to respond positively to environmental osmolarity are fundamental to ensuring embryo survival during the preimplantation period. Activation of p38 mitogen-activated protein kinase (MAPK) occurs following exposure to hyperosmotic treatment. Recently, a novel scaffolding protein called Osmosensing Scaffold for MEKK3 (OSM) was linked to p38 MAPK activation in response to sorbitol-induced hypertonicity. The human ortholog of OSM is cerebral cavernous malformation 2 (CCM2). The present study was conducted to investigate whether CCM2 is expressed during mouse preimplantation development and to determine whether this scaffolding protein is associated with p38 MAPK activation following exposure of preimplantation embryos to hyperosmotic environments.
Background
Culture medium osmolarity is one of the primary parameters that must be considered when formulating an optimized medium for the production of preimplantation embryos. Even brief exposure of preimplantation embryos to 300 mOsm/kg culture media (in the absence of osmolytes) results in impaired development [1] [2] [3] .
Most mammalian embryo culture media formulations have employed osmolarities around 250 mOsm/kg. Greater culture medium osmolarities may be employed but only in the presence of osmolytes such as glycine, betaine, proline and glutamine [2, 4] . Preimplantation embryos express a number of transporters that serve to regulate and maintain embryonic cell volume [5] [6] [7] . In somatic cell systems, activation of p38 MAPK is a common response of these osmoregulatory pathways [8, 9] .
MAPKs function by propagating extracellular signals via a series of phosphorylation events through sequentially arranged protein kinases, resulting in cellular responses ranging from transcriptional to post-translational events [10] . p38 MAPK consists of four mammalian isoforms including MAPK14/p38α [11] , MAPK11/p38β [12] , MAPK12/p38γ [13] , and MAPK13/p38δ [14] . p38 MAPKs are activated by a variety of environmental stresses and proinflammatory cytokines resulting in phosphorylation of the Thr-Gly-Tyr phosphoacceptor sequence [10, 15] . Directly upstream of p38 MAPK, there are at least three dual specificity Thr-Tyr kinases identified that phosphorylate and activate p38: MAP2K3 (or MKK3) [16] , MAP2K6 (or MKK6) [17] , and MAP2K4 (or MKK4) [16] . Downstream substrates of the p38 MAPKs include protein kinases such as MAPK-activated protein kinase 2 (MAPKAPK2) [18] and p38 regulated/activated kinase (PRAK/MAPKAPK5) [19] , as well as several transcription factors including MEF2, CHOP, and ATF2 [10] .
The discovery of a class of compounds called cytokinesuppressive anti-inflammatory drugs (CSAIDs) has allowed for the specific pharmacological inhibition of MAPK14/p38α and MAPK11/p38β isoforms [20] . The most extensively characterized CSAIDs are the pyridinyl imidazoles SB203580 [21] and the more potent SB220025 [22] . We have reported that all four p38 MAPK isoforms are expressed throughout mouse preimplantation development [23] . In addition, embryos treated with CSAIDs experience a reversible blockade of development at the 8-16 cell stage which is accompanied by a reversible loss of filamentous actin (F-actin) [23, 24] . These results point towards an essential role for MAPK14/11 in directing development of the mouse embryo past the 8-16 cell stage [23] [24] [25] .
Among its possible roles in the early embryo, p38 MAPK signaling is likely to mediate embryonic responses to hyperosmotic stimuli. Recently, a novel scaffolding protein called Osmosensing Scaffold for MEKK3 (OSM) was characterized [26] . OSM binds to F-actin, the GTPase, RAC, and the upstream kinases MAP3K3/MEKK3 and MAP2K3 in the p38 MAPK phospho-relay module, recruiting these proteins to sites of active membrane ruffling and newly polymerized actin ( Figure 1 ) [26] . Downregulation of OSM by RNA interference demonstrated that MAP3K3 and OSM were required for p38 MAPK activation in response to sorbitol-induced hypertonicity [26] . The current mouse gene name for OSM is cerebral cavernous malformation 2 homolog (human) (CCM2).
The present study was conducted to investigate whether CCM2 and upstream p38 MAPK pathway constituents are expressed during preimplantation development and to determine whether changes in CCM2 expression are associated with p38 MAPK activation following exposure of preimplantation embryos to hyperosmotic stimuli. Our results indicate that CCM2 is expressed throughout mouse preimplantation development and its protein levels are elevated in response to hypertonic culture conditions and correlate with increased p38 MAPK activity in the early embryo.
Results
Detection of mRNA transcripts encoding Ccm2, Map3k3, Map2k3, Map2k6, and Map2k4 during mouse preimplantation development Qualitative RT-PCR methods resulted in the detection of mRNA transcripts encoding Ccm2, Map3k3, Map2k3, Map2k6 and Map2k4 producing the expected size amplicons of 371 bp, 374 bp, 387 bp, 395 bp and 363 bp respectively throughout mouse preimplantation development in all 3 experimental replicates ( Figure 2A ). The identity of each RT-PCR product was confirmed through direct sequencing and BLAST ® analysis. RT-PCR products amplified using Ccm2, Map3k3, and Map2k3 primers possessed 100% sequence identity with their respective GenBank ® mouse nucleotide sequences. RT-PCR products amplified using Map2k6 and Map2k4 primers possessed 98% and 99% sequence identity with their corresponding GenBank ® mouse nucleotide sequences, respectively.
Relative abundance of mRNAs encoding Ccm2, Map3k3, Map2k3, Map2k6, Map2k4 and Mapk14 during mouse preimplantation development Ccm2 ( Figure 2B ) and Map2k6 ( Figure 2E ) mRNA steady state levels were significantly highest at the blastocyst stage (P ≤ 0.05) and did not vary significantly between the morula and 1-cell stages (P > 0.05). However, both Ccm2 and Map2k6 mRNA levels decreased significantly from 1-cell levels to those observed at the 2-cell, 4-cell, and 8-cell stage (P ≤ 0.05). Map3k3 ( Figure 2C ) and Map2k3 ( Figure  2D ) steady state mRNA levels were significantly highest at the morula and blastocyst stages (P ≤ 0.05). In contrast, Map2k4 ( Figure 2F ) steady state mRNA levels were highest at the 1-cell stage and declined significantly at the 2-cell stage (P ≤ 0.05). Map2k4 mRNA levels then remained low throughout preimplantation development, but did increase significantly (P ≤ 0.05) at the morula and blastocyst stages ( Figure 2F ). Finally, Mapk14 ( Figure 2G ) steady state mRNA levels were significantly highest (P ≤ 0.05) at the blastocyst stage. Mapk14 mRNA levels gradually declined from the 1-cell stage to reach their lowest level at the 8-cell stage before increasing significantly (P ≤ 0.05) again at the morula and blastocyst stages. CCM2 as a Scaffold for p38 MAPK Activation. As described in [26] the Rho-GTPase, RAC, is recruited to actin membrane ruffles by CCM2 following hyperosmotic stress, facilitating the activation of p38 MAPK. CCM2 acts as a scaffold binding to RAC, MAP3K3, and MAP2K3 to organize these components into a functional signaling module. We have included in this model the two additional upstream MAP2Ks to p38 MAPK: MAP2K6, a specific activator of p38 MAPK related to MAP2K3; and MAP2K4, which primarily activates the JNK/SAPK pathway, but can also phosphorylate p38 MAPK in vitro. These two kinases may contribute to activating p38 MAPK in response to hyperosmotic stress but unlikely via interactions with CCM2 [26] . Downstream substrates of p38 MAPK include MAPKAPK2 and MAPKAPK5. Representative image of three independent replicates. Quantitative analysis of Ccm2 (B), Map3k3 (C), Map2k3 (D), Map2k6, (E), Map2k4 (F) and Mapk14 (G). mRNA transcript levels in a developmental series of mouse preimplantation embryos by Real-Time RT-PCR. Data are normalized to Luciferase control (0.025 pg/embryo) and relative to 1-cell target gene mRNA levels. Relative mRNA levels are presented as the mean ± s.e.m. representative of three independent replicates. Bars with different letters represent significant differences in relative mRNA levels between embryo stages (P ≤ 0.05). (Figure 3 p-MAP2K4 1-cell to blastocyst) were also detected throughout preimplantation development. Phosphorylated MAP2K3/MAP2K6 was detected in the cytoplasm and the nucleus at all preimplantation stages of mouse development although the nuclear fluorescence was more intense than the cytoplasmic fluorescence. Phosphorylated MAP2K4 was primarily confined to the nucleus of each blastomere throughout preimplantation development ( Figure 3 p-MAP2K4 1-cell to blastocyst). In some cases faint phosphorylated-MAP2K4 immunofluorescence was detected in the cytoplasm. This was not consistent and was not restricted to a particular embryo stage ( Figure 3 p-MAP2K4 1-cell to blastocyst). For all proteins these distribution patterns were consistently observed in both trophectoderm and inner cell mass cell types of the blastocyst.
Effect of culture in 1800 mOsm hyperosmotic medium on blastocyst morphology and p38 MAPK activation We initially employed treatment with high culture osmolarity (i.e. 1800 mOsm) to explore the effects of an extreme treatment paradigm on phospho-MAPKAP2 fluorescence. Blastocyst culture in KSOMaa media containing 10% glycerol or 1.4 M sucrose resulted in an instantaneous decrease in blastocyst volume. Those placed in medium + 10% glycerol displayed a rapid recovery (5 minutes) back to normal volume, however, this recovery was not observed in embryos placed in 1.4 M sucrose medium (data not shown). Phospho-MAPKAPK2 immunofluorescence increased in blastocysts cultured in KSOMaa + 1.4 M sucrose for 10 minutes ( Figure 4C ) or for 30 minutes ( Figure 4G ) when compared to blastocysts cultured in KSOMaa + 10% glycerol for 10 minutes (Figure 4B ) or 30 minutes ( Figure 4F ), or when compared to blastocysts cultured in normal KSOMaa control media (control) for 10 minutes ( Figure 4A ) or 30 minutes (Figure 4E) . Quantitation of phospho-MAPKAPK2 immunofluorescence by Scion Image analysis demonstrated that 10 minutes of culture in KSOMaa + 1.4 M sucrose resulted in a significant increase (P ≤ 0.05) in relative signal strength (RSS; mean ± s.e.m.) when compared to normal KSOMaa cultured controls and also blastocysts cultured in KSOM + 10% glycerol [2.04 ± 0.17 (n = 14), 1.00 + 0.04 (n = 33), and 1.13 ± 0.06 (n = 25), respectively] ( Figure  4I ). The RSS of blastocysts cultured in KSOMaa + 10% glycerol displayed was not significantly different from normal KSOMaa cultured controls ( Figure 4I ). Figure 4S ). The RSS of phosphorylated MAPKAPK2 immunofluorescence in blastocysts cultured in KSOMaa + 1.4% glycerol did not differ from KSOMaa only controls ( Figure 4S ). At the 30 minute time-point, the RSS of blastocysts cultured in KSOMaa + 0.2 M sorbitol was significantly higher (P ≤ 0.05) than that observed for blastocysts cultured in KSOMaa + 1.4% glycerol and KSOMaa only controls [1.46 ± 0.12 (n = 35), 0.911 ± 0.082 (n = 35), and 1.00 ± 0.08 (n = 33), respectively] ( Figure 4T ). Once again there was no significant difference in the RSS displayed by blastocysts cultured in the glycerol medium and normal KSOMaa medium controls ( Figure 4T ).
Effect of 460 mOsm hyperosmotic treatment on Ccm2 transcripts and CCM2 protein
To explore a possible mechanism for the induction of p38 MAPK following incubation in hyperosmotic medium we next examined the influence of exposure to hyperosmotic medium on Ccm2 expression. We employed the 460 mOsm culture medium treatment for these experiments since we had now established that this treatment was sufficient to significantly increase phospho-MAPKAPK2 immunofluorescence levels. Cultured blastocyst stage mouse embryos were exposed to hyperosmotic treatment for 3, 6, 9, 12, or 24 hours in KSOMaa + 0.2 M sorbitol (460 mOsm) and compared with cultured blastocysts in normal KSOM medium (control group, 260 mOsm). No significant differences (P > 0.05) in relative Ccm2 mRNA transcript levels were observed between blastocysts cultured in the KSOMaa + 0.2 M sorbitol and blastocysts cultured in the normal KSOMaa medium control group at any of the investigated time-points ( Figure 5A ). Despite
Immunofluorescence Detection of CCM2, MAP3K3, Phosphorylated MAP2K3/6 and Phosphorylated MAP2K4 during Mouse Preimplantation Development Figure 5B-E) . Results from the quantification of CCM2 immunofluorescence are presented as relative signal strength (RSS) (mean ± s.e.m.) ( Figure 5F ). Following 15 minutes of treatment in 460 mOsm medium, blastocysts cultured in KSOMaa + 0.2 M sorbitol (n = 26) displayed a significant increase in RSS of CCM2 immunofluorescence when compared to blastocysts cultured in normal KSOMaa medium (n = 26) (1.74 ± 0.09 vs. 1.00 ± 0.10, respectively) or KSOMaa containing 1.4% glycerol (n = 27) (1.74 ± 0.09 vs. 0.926 ± 0.077, respectively) (Figure 5F) (P ≤ 0.05). Blastocysts cultured in KSOMaa + 1.4% glycerol did not display a significant difference in RSS from blastocysts cultured in normal KSOMaa medium ( Figure 5F ).
Discussion
Our overall objective was to increase our understanding of the intracellular signaling pathways that respond to the external environment and regulate preimplantation development. Our recent characterization of the expression of all four isoforms of p38 MAPK (MAPK14/p38α, MAPK11/p38β, MAPK12/p38γ, and MAPK13/p38δ) and a number of its downstream substrates provided the foundation for our current studies [23] . We have recently demonstrated a requirement for p38 MAPK signaling during preimplantation development by characterizing the reversible developmental blockade that occurs at the 8-to 16-cell stage following inhibition of MAPK14/p38α and MAPK11/p38β isoforms [23] . Furthermore, p38 MAPK regulates F-actin polymerization during preimplantation development via phosphorylation of downstream substrates MAPKAPK2 and PRAK/MAPKAPK5, and subsequently through the small heat shock proteins, HSPB1/2 [23, 24] . Our present study has extended these initial investigations into p38 MAPK function during preimplantation development by addressing the upstream events in the three-tiered MAPK pathway module. Our first objective was to characterize the expression of regulatory kinase gene products upstream of p38 MAPK during preimplantation development. At the protein level, the CCM2 and MAP3K3 cytoplasmic distribution pattern observed following application of whole-mount indirect immunofluorescence was as expected considering the role of CCM2 as an actin binding scaffold protein and MAP3K3 as an upstream MAP3K that is responsive to extracellular stimuli at the cell surface. The diffuse cytoplasmic distribution mirrors the localization pattern displayed by these proteins in HEK293 and COS7 cell lines [26, 27] . We also determined the distribution of phosphorylated MAP2K3/MAP2K6 proteins and MAP2K4 proteins throughout mouse preimplantation development. The use of antisera recognizing the phosphorylated forms of these proteins allowed us to not only characterize their distribution throughout preimplantation development but also report their activation during preimplantation development. Activated MAP2Ks were detected in the cytoplasm and nucleus of embryos collected from the 1-cell to the blastocyst stage, indicating that the p38 MAPK pathway is activated from the earliest stages of development onward. While phospho-MAP2K3/MAP2K6 proteins were detected in the cytoplasm and the nucleus, phospho-MAP2K4 proteins were confined to the nuclei, suggesting that p38 MAPK phosphorylation by MAP2K4 may occur predominantly in the nucleus. This nuclear localization is supported by studies that investigated the activation of JNK/SAPK in P19 embryonic carcinoma cells [28] . MAP2K4 was detected in both the nucleus and cyto- . In total, these results establish the presence of all components of the Rac-CCM2-MAP3K3-MAP2K3 signaling complex throughout preimplantation development when coupled with our previous studies that determined Rac1 expression during mouse preimplantation development ( Figure 1) [31].
Since it is well known that the roles played by p38 MAPK extend well beyond the regulation of the actin cytoskeleton our present study investigated whether embryonic p38 MAPK signaling is affected by exposure to hyperosmotic stimuli as is reported for somatic cells. Our results clearly demonstrate that hyperosmotic treatment during culture increased p38 MAPK activity as assessed by increased phosphorylation of its specific downstream substrate, MAPKAPK2. These findings are supported by numerous studies that have described the responsiveness of this pathway to hyperosmotic stress, and have indicated that increases in p38 MAPK activity are a common cellular response to hyperosmotic stimuli (reviewed by [9] . While the increased p38 MAPK activity and phosphorylation of MAPKAPK2 in itself is not a novel discovery, the responsiveness of p38 MAPK to hyperosmotic stress has not until now been demonstrated to occur during preimplantation development. One of the most exciting outcomes from our study is the differential activation of p38 MAPK that occurred in response to the solute compound used to increase the osmolarity of embryo culture media.
At both 1800 mOsm and 460 mOsm hyperosmotic treatment conditions, the addition of glycerol to KSOMaa culture medium did not result in a significant increase in phospho-MAPKAPK2 immunofluorescence in blastocysts. This is in contrast to the 1.4 M sucrose (1800 mOsm) and 0.2 M sorbitol (460 mOsm) treatments in which a significant increase in phospho-MAPKAPK2 immunofluorescence was detected at two treatment timepoints. We propose that this difference in p38 MAPK activation is a result of the alleviation of osmotic stress and restoration of osmotic equilibrium across the cell membrane due to aquaporin (AQP; water channel) mediated glycerol permeability. This likelihood is supported by our previous studies which demonstrated the selective permeability of water and glycerol, but not sucrose, through apical and basolateral AQPs located in the blastocyst trophectoderm [32, 33] . Since glycerol can permeate the cell membrane relatively freely via AQPs, the initial osmotic gradient (from 260 mOsm to 1800 mOsm or 460 mOsm) produced by the addition of glycerol to culture media is rapidly reversed in these treatment groups, alleviating "osmotic stress" that might induce p38 MAPK 
Conclusion
In conclusion, we have demonstrated for the first time that transcripts and polypeptides encoding MAP3K3, MAP2K3, MAP2K6, MAP2K4 and CCM2 are expressed and localized throughout mouse preimplantation development. We have discovered that p38 MAPK activity is regulated by exposure to hyperosmotic stimuli, and that the response to hyperosmotic stress in the early embryo includes increased CCM2 levels. These outcomes provide a basis for understanding the mechanisms controlling osmotic induction of p38 MAPK activity during preimplantation development. The outcomes therefore further our knowledge of the regulation of intracellular signaling pathways within the mammalian embryo and understanding of how culture environments can affect embryo development. The preimplantation embryo is highly sensitive to the environment in which it develops. With the extension of embryo culture to the blastocyst stage emerging as a routine treatment paradigm in human infertility clinics, it becomes even more important that we study the short-term and long-term effects of culture on embryo development. Our results may therefore contribute to advancements in the development of improved embryo culture systems with the ultimate goal of increasing our ability to produce healthy embryos for embryo transfer.
Methods

Superovulation and mouse embryo collection
Female CD-1 (6-8 weeks of age, Charles River Laboratories, Saint-Constant, QC, Canada) or MF-1 mice (4-5 weeks of age, Harlan Sprague Dawley, Indianapolis, IN, USA) were superovulated by intraperitoneal (IP) injection of 10 IU pregnant mare serum gonadotropin (PMSG; Intervet Canada Ltd., Whitby, ON, Canada) followed 48 hours later by 10 IU human chorionic gonadotropin (hCG; Intervet Canada Ltd., Whitby, ON, Canada) prior to mating with CD-1 males (Charles River Laboratories, Canada) as described [23, 24, 41] . Embryos were collected at specified times following hCG injection, which correspond to appropriate cleavage stages: 1-cell zygotes 24 hr post-hCG; 2-cell, 48 hr; 4-cell, 60 hr; 8-cell, 65-68 hr; morulae, 80-85 hr and blastocyst, 90 hr. Embryos were collected by either flushing reproductive tracts with flushing medium 1 (1-cell -8-cell stages) or flushing medium II (morulae and blastocysts) [42] . Embryos were washed several times in flushing medium and collected in pools to be either: 1) frozen and stored at -80°C for RNA extraction; 2) fixed for immunofluorescence analysis of protein distribution; or 3) cultured in 20 μL drops of EmbryoMax ® KSOMaa (potassium simplex optimized medium with amino acids) Liquid Mouse Embryo Media (Chemicon International -Specialty Media, Temecula, CA, USA) [43] under mineral oil and maintained in culture under 5% CO 2 in air atmosphere at 37°C. Animal care and treatment followed protocols established by the UWO Animal Care Committee. 
RNA extraction
Reverse Transcription and Polymerase Chain Reaction (RT-PCR)
Embryo total RNA was reverse transcribed (RT) using Random Primers (Invitrogen Life Technologies, Burlington, ON, Canada) and RNaseOUT™ Ribonuclease Inhibitor (Invitrogen Life Technologies, Burlington, ON, Canada) along with Sensiscript RT (Qiagen Inc., Mississauga, ON, Canada) according to the manufacturer's suggested protocol. Following one hour incubation, the sample was diluted to a concentration of 1 embryo equivalent per μL (embryo/μL) and subjected to PCR amplification of H2A histone family, member Z (H2afz), Luciferase, or both to determine the efficiency of the RNA extraction and reverse transcription prior to investigation of expression of the target genes through standard and Real-Time PCR amplification. Polymerase chain reaction (PCR) was performed using one embryo equivalent of cDNA from each stage per reaction in a 50 μL volume consisting of 1. Table 1 . Qualitative PCR amplification reactions were performed using a Techne Touchgene Gradient DNA thermal cycler (Techne Inc., Burlington, NJ, USA). The reaction was initiated at 95°C for 5 minutes, followed by 40 cycles consisting of denaturation at 95°C for 50 seconds, reannealing primers to target sequence at 60°C for 50 seconds, and primer extensions at 72°C for 50 seconds. Each amplification reaction was terminated with a 10 minute final extension at 72°C. PCR products were resolved on a 2.0% agarose gel containing 1.0 μg/mL ethidium bromide (Invitrogen Life Technologies, Burlington, ON, Canada) in 1X TAE buffer (40 mM Tris, 40 mM acetate, 1 mM EDTA). The identity of all PCR products was confirmed by sequence analysis (DNA Sequencing Facility, Robarts Research Institute, London, ON, Canada). PCR reactions were repeated a minimum of three times using cDNA prepared from embryos at each of the indicated stages and isolated from a minimum of three separate developmental series. Positive (tissue cDNA: heart, liver, and kidney) and negative control (no cDNA template) samples were included for each primer set in every experiment.
Custom TaqMan ® gene expression assay design for realtime PCR
The Custom TaqMan ® primer and probe sets for Ccm2 and Luciferase were designed using the Assays-by-Design File Builder program (Applied Biosystems, Foster City, CA, USA). The probe sequence for CCM2 was designed against a target site 847 bp into the full-length sequence obtained from the Ensembl mouse transcript database (Transcript ID: ENSMUST00000000388). The probe sequence for luciferase was directed against a target site 550 bp into the full-length sequence used to generate the Luciferase Con-trol RNA (Promega Corporation, Madison, WI, USA). The target site specifies an approximate location for generation of a TaqMan ® probe, and each target site was verified to be unique by performing BLAST ® analysis. Dual-labeled probes were synthesized (Applied Biosystems, Foster City, CA, USA) to contain the reporter dye 6-carboxyfluorescein (6-FAM) at the 5' end and a non-fluorescent quencher dye at the 3' end.
Quantitative real-time PCR analysis
Real-Time PCR reactions were performed using the ABI PRISM ® 7900HT sequence detection system (Applied Biosystems, Foster City, CA, USA) and TaqMan Relative quantification of target gene expression levels was performed using the comparative C T (threshold cycle) method (ABI PRISM ® Sequence Detection System, version 2.1, Applied Biosystems, Foster City, CA, USA). The quantification was normalized to the control luciferase RNA levels [44] . Within the log linear phase region of the amplification curve, the difference between each cycle was equivalent to a doubling of the amplified product of the PCR. The ΔC T value was determined by subtracting the control C T value for each sample from the target gene C T value of the sample. Calculation of ΔΔC T used either the 1-cell or control sample as a standard. Fold-changes in the relative mRNA expression of the target gene were determined using the formula 2 -ΔΔCT .
Antisera
Rabbit antisera raised against the phosphorylated forms of phospho-MKK3/MKK6 (Ser189/207), phospho-SEK1/ MKK4 (Thr261), and phospho-MAPKAPK2 (Thr334) were used (Cell Signaling Technologies Inc., Danvers, MA, USA). The anti-MEKK3 antiserum used was a mouse monoclonal antibody (BD Biosciences Pharmingen, San Diego, CA, USA). The rabbit polyclonal anti-OSM/CCM2 antiserum was a gift generously donated by Dr. Gary L. Johnson (University of North Carolina at Chapel Hill) [26] . All primary antisera were used at a dilution of 1:100, with the exception of anti-OSM/CCM2 at a dilution of 1:200, from the commercial or provided stock concentration. Primary antibodies were labeled using fluorescein (FITC)-conjugated donkey anti-rabbit secondary antisera (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA) and FITC-conjugated donkey anti-mouse secondary antisera (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA). 
Image analysis and quantification of immunofluorescence intensity
To quantify immunofluorescence results we employed the method developed and reported by [45] . All microscope and image capture settings remained constant during the digital capture of confocal micrographs between embryos and between treatment groups. Acquired micrographs were saved in TIFF image format and processed using Adobe Photoshop CS2 (Adobe Systems Inc., San Jose, CA, USA), for recognition, selection and separation of the desired chromogen signal. Quantitative analysis began by separation of the green image channel representing FITC fluorescence of phospho-MAPKAPK2 from the red (representing rhodamine-phalloidin-labelled F-actin) and blue (representing DAPI-stained nuclei) channels. The green channel image was converted to "Grayscale", discarding the other two color channels to ensure the signal remaining represented only FITC fluorescence. . The osmolarity of the embryo culture medium was tested by freezing-point depression using the Advanced ® Model 3320 MicroOsmometer (Advanced Instruments Inc., Norwood, MA, USA). For Real-Time PCR analysis, embryos were treated for 3, 6, 9, 12, or 24 hours prior to determination of transcript levels by real-time RT-PCR as described above. For whole-mount indirect immunofluorescence assays, embryos were treated for times ranging from 10 to 30 minutes and then were processed for whole-immunofluorescence methods as described above. 
Statistical analysis
